Marshall Wace
ASTH icon

Marshall Wace’s Astrana Health ASTH Stock Holding History

Marshall Wace’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-89,472
Closed -$2.82M – 3168
2024
Q4 		$2.82M Buy
+89,472
New +$4.25M ﹤0.01% 1308
2024
Q1 		– Sell
-58,189
Closed -$2.23M – 2867
2023
Q4 		$2.23M Buy
58,189
+33,906
+140% +$1.13M ﹤0.01% 1173
2023
Q3 		$749K Buy
24,283
+3,583
+17% +$124K ﹤0.01% 1586
2023
Q2 		$654K Sell
20,700
-2,668
-11% -$91.5K ﹤0.01% 1889
2023
Q1 		$852K Buy
23,368
+4,768
+26% +$167K ﹤0.01% 1891
2022
Q4 		$550K Buy
18,600
+1,229
+7% +$39.5K ﹤0.01% 2336
2022
Q3 		$678K Buy
+17,371
New +$795K ﹤0.01% 2598
2021
Q1 		– Sell
-13,362
Closed -$244K – 2921
2020
Q4 		$244K Sell
13,362
-2,422
-15% -$43.5K ﹤0.01% 1707
2020
Q3 		$284K Buy
+15,784
New +$272K ﹤0.01% 1376
2019
Q2 		– Sell
-12,201
Closed -$224K – 1917
2019
Q1 		$224K Sell
12,201
-24,353
-67% -$467K ﹤0.01% 1314
2018
Q4 		$726K Buy
+36,554
New +$684K 0.01% 999

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall Wace's ASTH Position: Q1 2025 in Review

Marshall Wace sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 89,472 shares — an estimated $2.82M sold.

Marshall Wace first reported a position in ASTH in Q4 2018 and held it in 11 quarters. The position peaked at $2.82M in Q4 2024. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Marshall Wace reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 89,472 Astrana Health shares in Q1 2025, an estimated $2.82M.
  • Marshall Wace first reported a position in Astrana Health in Q4 2018 and held it in 11 quarters.
  • Marshall Wace's Astrana Health position peaked at $2.82M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.